Mendelian randomization studies on the causal relationship between insomnia and disease

Area of Science:

• Genetics
• Epidemiology
• Sleep Medicine

Background:

• Insomnia is a common sleep disorder with serious health implications.
• Observational studies on insomnia's health effects are limited by confounding factors and unclear causality.
• Mendelian randomization offers a robust method to establish causal relationships using genetic variants.

Purpose of the Study:

• To systematically review Mendelian randomization studies investigating the causal effects of insomnia on various diseases.
• To clarify the causal direction between insomnia and associated health conditions.
• To provide genetic evidence for insomnia as a modifiable risk factor.

Main Methods:

• Systematic review and integration of 105 Mendelian randomization studies.
• Utilizing genetic instrumental variables for causal inference in insomnia research.
• Analyzing evidence for causal links between insomnia and a wide range of diseases.

Main Results:

• Insomnia causally increases the risk of coronary heart disease, anxiety-depressive disorders, type 2 diabetes, and chronic pain.
• Evidence suggests potential causal links with osteoarthritis and lung cancer, albeit with smaller effect sizes.
• Causal associations with Alzheimer's disease and schizophrenia were not confirmed.
• A dominant causal direction from insomnia to disease was established, mitigating reverse causality bias.

Conclusions:

• Insomnia is a significant, modifiable causal factor for numerous physical and mental health disorders.
• Genetic evidence supports targeting insomnia for the prevention and management of related diseases.
• Findings facilitate early identification of at-risk individuals and personalized interventions.